Tenant improvement costs for STEM-related office properties can be more than 3x the cost of traditional TIs, says Kennedy Wilson’s Nick Colonna, amid calls to be “defensive” in underwriting property rehab costs.

How are GPs creating value in a disrupted, rapidly evolving market?

Michael Milken’s very personal battle with skin cancer.

BC Partners’ Nikos Stathopoulos gives an overview his firm’s successful investment in Turkish supermarket chain Migros.

Baird Capital’s Mike Liang discusses the appeal of investing in a company that makes products aimed at preventing hospital-acquired infections.

Private equity managers are increasingly focused on value creation to help offset the high prices in today’s competitive economic cycle, says EY’s Michael Rogers.

Experts from J.F. Lehman, Vestar Capital and RSM explain the carve-out process, including sourcing, transactions and value creation.

With cap rates and interest rates at historic lows, today is a great time for corporations to unlock the value of their real estate holdings, say experts from W. P. Carey, KKR, and MB Real Estate.

An expert Q&A with Stuart Taub of RSM on the risks facing real estate GPs, from increased scrutiny by regulators to the added complexity of structuring for foreign investors.

A panel of experts explains how foreign and HNW investors are reshaping the U.S. real estate market, buying deals in the 3 percent cap rate range, or where price simply isn’t an issue.

Lincolnshire Management’s president, Michael Lyons discusses the firm’s operational expertise, with many of its professionals coming from operations backgrounds

Many private equity firms are seeing a correlation between a robust ESG strategy and a higher IRR, says Michael Rogers of EY.